Search

• Actinidia arguta is a source of bioactive compounds for food industry. • Bioactive compounds from A. arguta are reviewed. • A. arguta has high nutritional, functional and economic value. • Health promoting effects of A. arguta have been confirmed in vitro and in vivo. • A. arguta can be used in the prevention/treatment of chronic diseases (e.g. diabetes). Hardy kiwi (Actinidia arguta) is a climbing, perennial and dioecious vine from Actinidiaceae family, native from Asia and valued as ornamental and traditional medicine. In the last decade, the growing interest as fruit-bearing plant encourage the expanding cultivation of A. arguta mainly to fruits production, particularly in Europe and North America. A. arguta plants have an extensive range of bioactive compounds that can be obtained from different botanical structures, such as fruits, leaves, flowers and stems. These bioactive molecules, with well-recognized health-promoting properties, include phenolic compounds, minerals, carbohydrates or even volatile substances, with a great potential to be used in several formulations of food products. Phytochemical studies on this plant reported hypoglycemic effects as well as antioxidant and anti-inflammatory activities, among others. The traditional uses of A. arguta have been experimentally proved by in vitro and in vivo studies, in which its bioactivities were associated to its phytochemical composition. This review aims to assess and summarize the phytochemical and healthy properties of the different botanical parts of A. arguta , describing their bioactive composition and exploring it potential functional properties on foodstuffs. [ABSTRACT FROM AUTHOR]